4005
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Sumitomo Chemical Company, Limited is a diversified chemical and pharmaceutical group operating through five main business segments. The Agro & Life Solutions segment manufactures and sells pesticides, fertilizers, agricultural materials, household and public health insecticides, and feed additives. The ICT & Mobility Solutions segment produces optical products, semiconductor process materials, compound semiconductor materials, touch sensor panels, high-purity aluminum, engineering plastics, and battery components. The Advanced Medical Solutions segment provides contract development and manufacturing services for low-molecule pharmaceuticals, oligonucleotides, and regenerative cell therapies. The Essential & Green Materials segment manufactures synthetic resins, synthetic fiber raw materials, industrial chemicals, metacrylate, and synthetic rubber. The Sumitomo Pharma segment develops and sells low-molecule pharmaceuticals. The group also engages in power and steam supply, transportation, and warehousing. Key subsidiaries include Sumitomo Biochemical Company LLC, Sumitomo Chemical Brazil, Sumitomo Chemical Chile, Sumitomo Chemical India, Toyoka Fine Chemical, Sumika Semiconductor Materials Texas, SSLM, Sumitomo Chemical America, Sumika Polymers America, Sumitomo Chemical Asia, Hiroe Chemical, Nippon Singapore Petrochemical, PCS Private Limited, The Polyolefin Company, Lavig Refining and Petrochemical Company, Sumitomo Pharma, Sumitomo Pharma America, Sumitomo Pharma Suisse, and Euroviant Sciences. The company was founded in 1913.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Chemicals Homepage sumitomo-chem.co.jp
Sector Basic Materials IR page sumitomo-chem.co.jp/ir
Tags
agrochemicals, semiconductor materials, pharmaceuticals, contract manufacturing, synthetic resins, optical products, battery components, industrial chemicals, synthetic rubber, metacrylate, Sumitomo Biochemical Company LLC, Biorant Bioscience LLC, Biorant U.S.A. LLC, Sumitomo Chemical Brazil Industria Quimica S.A., Sumitomo Chemical Chile S.A., Sumitomo Chemical India Limited, Toyoka Fine Chemical, Sumika Semiconductor Materials Texas Incorporated, SSLM, Sumitomo Chemical Electronic Materials Technology (Wuxi) Co. Ltd., Sumitomo Chemical Technology Co. Ltd., Tanaka Chemical Research Institute, Toka Chemical Industry, Hiroe Chemical, Nippon Singapore Petrochemical, PCS Private Limited, The Polyolefin Company (Singapore) Private Limited, Lavig Refining and Petrochemical Company, Sumitomo Chemical America Incorporated, Sumika Polymers America Corporation, Sumitomo Chemical Asia Private Limited, Sumitomo Pharma, Sumitomo Pharma America Incorporated, Sumitomo Pharma Suisse GmbH, Euroviant Sciences GmbH, Sumitomo Seika, Biondo, CFP-TOMO
Press page sumitomo-chem.co.jp/english/ir/news

Metrics

Valuation  
Market cap ¥ 948.563B
Market cap (USD) $ 5.943B
P/E 9.06
PEG 0.09
P/BV 0.64
P/S 0.39
P/OCF 3.89
P/FCF 8.38
Dividend yield 2.4%
Turnover / mcap —
Returns  
ROE 5.3%
ROI 2.6%
ROIC 6.3%
Profit margin 2.6%
Growth  
Revenue growing No
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 105.9%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score -5.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 2.329T 2.606T 2.447T 2.895T 2.765T 2.287T 2.226T 2.319T 2.217T 1.954T 2.102T 2.377T 2.244T 1.952T
Net profit 60.947B 38.591B -311.838B 6.987B 162.13B 46.043B 30.926B 117.992B 126.039B 85.482B 81.451B 52.192B 36.977B -51.076B
Free cash flow 113.199B 101.302B -209.722B -29.46B 52.192B 261.76B -10.336B 44.48B — 55.691B 171.407B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 499.43 361.41 338.62 444.94 562.05 572.99 321.07 515.08 620.14 622.03 508.96 617.95 380.95 —
Price performance 12m 0.38 0.07 -0.24 -0.21 -0.02 0.78 -0.38 -0.17 -0 0.22 -0.18 0.62 — —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 455B 531B 550B 570B 653B 720B 603B 620B 594B 609B
↳ YoY growth +9.7% +3.7% +3.7% +14.4% +10.4% -16.3% +2.8% -4.2% +2.5%
↳ 5y CAGR +2.6% +2.4% +0.8% -1.4%
Borrowings, current (JPY) 302B 289B 257B 467B 250B 261B 397B 586B 253B 241B
Borrowings, non-current (JPY) 574B 553B 583B 838B 1.1T 1.09T 1.06T 978B 1.03T 910B
Bonds payable (JPY) 278B — — — — — — — — —
Cash and deposits (JPY) 193B 232B 202B 181B 361B 365B 306B 217B 210B 209B
Intangible assets (JPY) 358B 233B 217B 466B 450B 471B 404B 273B 239B 225B
Net debt (borrowings + leases - cash) (JPY) 714B 610B 638B 1.12T 990B 985B 1.16T 1.35T 1.08T 943B
Cash flow detail
Operating cash flow (JPY) 187B 288B 208B 106B 374B 172B 112B -51.3B 233B 235B
Purchases of property, plant and equipment (JPY) -132B — -164B -116B -113B -120B -141B -158B -132B -122B
Change in receivables (cash effect) (JPY) -32.2B -24.6B -26.6B -10.9B -22.4B -19.5B 134B 34.8B -22B -3.62B
Change in inventories (cash effect) (JPY) 2.45B -55.6B -35.6B -11.7B 12.6B -98.2B -79.9B 78.6B 56.5B 38.6B
Change in payables (cash effect) (JPY) 31.2B 73.6B -18.7B -22B 48.3B -39.2B -63.6B -32.3B -6.11B -71.9B
Dividends paid (cash effect) (JPY) -21.3B -27.8B -37.6B -36B -19.6B -31.1B -42.5B -19.6B -9.87B -19.7B
Share buybacks (cash effect) (JPY) -51M — — — — — — — — —
Interest paid (cash effect) (JPY) -10.7B -10.5B -10.9B -12.7B -15.9B -15.4B -21.8B -28.1B -27.5B -29.8B
Income taxes paid (cash effect) (JPY) -65.1B -28.7B -50.2B -48.7B -54.4B -68.3B -65.5B -48.3B -10.1B -27.4B
Operating cash flow before change in receivables (JPY) 220B 318B 235B 117B 397B 191B -22.9B -86.1B 255B 238B
Free cash flow (OCF - PPE - intangibles) (JPY) 55.7B — 44.5B -10.3B 262B 52.2B -29.5B -210B 101B 113B
Income detail
Research and development expense (JPY) 158B 162B 164B 174B 179B 175B 196B 184B 145B 145B
↳ 5y CAGR +3.8% +2.4% -3.6% -4.1%
Total comprehensive income (JPY) 105B 162B 148B -17.4B 136B 255B 65.6B -302B -54.6B 188B
Comprehensive income to owners (JPY) 88.3B 142B 110B -39.1B 109B 230B 84.1B -187B -54B 120B
Segments
Advanced Medical Solutions · Segment revenue (JPY) — — — — — — — 73.4B 72.5B 72.4B
↳ YoY growth -1.2% -0.2%
Advanced Medical Solutions · Segment operating income (JPY) — — — — — — — 6.06B 3.97B 2.82B
Agro And Life Solutions · Segment revenue (JPY) — — — — — — — 518B 541B 520B
↳ YoY growth +4.6% -3.9%
Agro And Life Solutions · Segment operating income (JPY) — — — — — — — 26.4B 55B 56.3B
Energy And Functional Materials · Segment revenue (JPY) — 257B 291B 265B 255B 329B 360B 317B — —
↳ YoY growth +12.9% -9.0% -3.8% +29.2% +9.5% -11.8%
Energy And Functional Materials · Segment operating income (JPY) — 19.2B 23B 20.3B 20.3B 20.1B 15.2B 7.83B — —
Essential And Green Materials · Segment revenue (JPY) — — — — — — — 891B 904B 683B
↳ YoY growth +1.4% -24.4%
Essential And Green Materials · Segment operating income (JPY) — — — — — — — -89.1B -58.5B 14.4B
Essential Chemicals And Plastics · Segment revenue (JPY) — — — — — 848B 859B 779B — —
↳ YoY growth +1.3% -9.2%
Essential Chemicals And Plastics · Segment operating income (JPY) — — — — — 53.5B -34.2B -90.7B — —
Health And Agriculture Related · Segment revenue (JPY) — 343B 344B 349B 428B 481B 604B 552B — —
↳ YoY growth +0.1% +1.6% +22.5% +12.3% +25.6% -8.6%
Health And Agriculture Related · Segment operating income (JPY) — 44B 19.7B 2.08B 31.5B 42.3B 57.3B 30.9B — —
ICT And Mobility Solutions · Segment revenue (JPY) — — — — — — — 591B 610B 575B
↳ YoY growth +3.2% -5.8%
ICT And Mobility Solutions · Segment operating income (JPY) — — — — — — — 50B 70.6B 53B
Information Electronic Chemistry · Segment revenue (JPY) — 370B 398B 406B 432B 474B 432B 415B — —
↳ YoY growth +7.6% +2.0% +6.5% +9.7% -9.0% -4.0%
Information Electronic Chemistry · Segment operating income (JPY) — 12.3B 26.2B 25.1B 39.7B 57.8B 47.6B 44B — —
Medical Products · Segment revenue (JPY) — 500B 492B 516B 546B 592B 585B 343B — —
↳ YoY growth -1.6% +4.8% +5.9% +8.3% -1.2% -41.4%
Medical Products · Segment operating income (JPY) — 94.8B 80.8B 75.3B 71.7B 61.7B 16.2B -133B — —
Petrochemistry · Segment revenue (JPY) — 681B 764B 663B 594B 848B — — — —
↳ YoY growth +12.2% -13.2% -10.4% +42.8%
Petrochemistry · Segment operating income (JPY) — 94.6B 61.6B 14.5B -12B 53.5B — — — —
Sumitomo Pharma · Segment revenue (JPY) — — — — — — — 314B 399B 453B
↳ YoY growth +26.9% +13.7%
Sumitomo Pharma · Segment operating income (JPY) — — — — — — — -126B 35.3B 108B
Reported Jun 21, 2018 Jun 21, 2019 Jun 21, 2019 Jun 24, 2020 Jun 23, 2021 Jun 21, 2023 Jun 21, 2023 Jun 20, 2025 Jun 20, 2025 Jun 22, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Sumitomo Chemical Company, Limited (ticker 4005), listed in Japan.

Company History

Date Change Detail
Jun 26, 2026 Acquired Acquired Koei Chemical Company, Limited (EDINET code E00837). Its filings from before the deal are on its own company page, not shown here.
Dec 26, 2025 Acquired Acquired Tanaka Chemical Corporation (EDINET code E01050). Its filings from before the deal are on its own company page, not shown here.

ETFs Holding Sumitomo Chemical Company, Limited

ETF Weight in ETF Shares Market value As of
AVIV 0.12% 817,300 $ 2.583M Nov 16, 2026
DXIV 0.08% 55,800 $ 181.638K Nov 12, 2026
AVDE 0.06% 3,858,700 $ 12.197M Nov 16, 2026
NTSI 0.05% 80,500 $ 254.341K Jun 30, 2026
DFIV 0.05% 3,386,899 $ 11.025M Nov 12, 2026
DFIC 0.04% 2,116,600 $ 6.89M Nov 12, 2026
DFSI 0.03% 123,683 $ 402.608K Nov 12, 2026
DFAX 0.03% 943,700 $ 3.072M Nov 12, 2026
DFAI 0.02% 1,382,400 $ 4.5M Nov 12, 2026
DIHP 0.00% 41,600 $ 135.415K Nov 12, 2026